Jänne, P. A., Wang, B., Cho, B. C., Zhao, J., Li, J., Hochmair, M., Peters, S., Besse, B., Pavlakis, N., Neal, J. W., Kato, T., Wu, Y., Nguyen, D., Lin, J., Lin, J., Vranceanu, F., Szumski, A., Lin, H. M., Fram, R. J., Mok, T. S. (2025). First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With
            <i>EGFR</i>
            Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01269